The news results from a risky gambit by drugmaker AstraZeneca (nyse: AZN - news - people ) to test the new medicine, Cerovive, in a 1, 700-patient Phase III clinical trial before proof of human efficacy was available.

FORBES: Winning A Battle In The War On Stroke

In other words, the choice to avoid the word Shariah is likely to be a central evidentiary proof at trial on the issue of scienter.

CENTERFORSECURITYPOLICY: Shariah��s Black Box

He has reminded himself that the burden of proof at any trial would be on the prosecution.

BBC: Straw's statement in full